Raymond James Financial’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.4M Buy
969,941
+37,943
+4% +$1.52M 0.01% 1049
2026
Q1
$33.7M Buy
931,998
+218,970
+31% +$8.4M 0.01% 1121
2025
Q4
$27.4M Buy
713,028
+42,591
+6% +$1.6M 0.01% 1225
2025
Q3
$24.3M Sell
670,437
-490,055
-42% -$17.1M 0.01% 1283
2025
Q2
$39.8M Buy
1,160,492
+105,834
+10% +$3.36M 0.01% 901
2025
Q1
$33M Buy
1,054,658
+261,608
+33% +$8.53M 0.01% 964
2024
Q4
$25.4M Buy
+793,050
New +$25.8M 0.01% 1141

Other funds holding QLTY

Raymond James Financial's QLTY Position: Q2 2026 in Review

Raymond James Financial increased its GMO US Quality ETF (QLTY) stake by 4.1% in Q2 2026, buying an estimated $1.52M and bringing the position to 969,941 shares worth $40.4M. The position accounts for 0.01% of the portfolio, ranked #1049.

Raymond James Financial first reported a position in QLTY in Q4 2024 and has held it in 7 quarters since. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Raymond James Financial held 969,941 shares of GMO US Quality ETF worth $40.4M as of Q2 2026.
  • Raymond James Financial bought 37,943 GMO US Quality ETF shares in Q2 2026, an estimated $1.52M.
  • GMO US Quality ETF made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1049 holding.
  • Raymond James Financial first reported a position in GMO US Quality ETF in Q4 2024 and has held it in 7 quarters since.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.